Vincera Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.60
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.55
|
-0.80
|
-0.25
|
-45.45%
|
|
2022-06-30
|
-0.79
|
-0.88
|
-0.09
|
-11.39%
|
|
2022-03-31
|
-0.76
|
-0.79
|
-0.03
|
-3.95%
|
|
2021-12-31
|
-0.93
|
-0.31
|
0.62
|
66.67%
|
|
2021-09-30
|
-0.85
|
-1.39
|
-0.54
|
-63.53%
|
|
2021-06-30
|
-0.37
|
-0.12
|
0.25
|
67.57%
|
|
2021-03-31
|
-0.32
|
-0.46
|
-0.14
|
-43.75%
|
|
2020-12-31
|
0.00
|
-2.04
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.47
|
|
2021-12-31
|
-2.28
|
|
2020-12-31
|
-2.38
|
|
2019-12-31
|
0.00
|